In addition, few cell-surface markers are completely cancer-specific, leading to side effects when antibodies attack healthy cells. Patrys, a Melbourne-based biotech company, is overcoming these ...
Elucidation of the mechanisms by which cell-surface calreticulin triggers immune responses will be essential in translating the work of Obeid et al. into improved cancer therapies.
The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance. In order to propagate malignancy, circRNAs shuttle ...
In Covid this antigen is part of the spike protein of the virus. In cancer it would be a marker on the surface of tumour cells. BioNTech founders say they have had a "number of breakthroughs" in ...
It contains information about several markers found on the surface of lung cancer cells to teach the patient's immune system what to find and fight. The BNT116 vaccine, made by German ...